Our brain and eyes can play tricks on us—not least when it comes to the expanding hole illusion. A new computational model ...

A unique collaboration between electrical engineers and ophthalmologists solves clinical, computational challenges.

However, the study provides limited new insights into the relationship between retinal lamination defects and overall retinal function. Neural lamination is a common feature of the central nervous ...

IZERVAY dosing approved beyond 12 months TOKYO, Feb. 12, 2025 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today ...

The Sing IMT improved distance and near vision at 6 months in patients with late-stage age-related macular degeneration, with ...

H.C. Wainwright analyst raised the price target on Ocugen, Inc. (NASDAQ:OCGN) to $8.00, up from the previous $7.00, while maintaining a Buy rating on the stock. Currently trading at $0.66, the stock ...

PulseSight Therapeutics SAS, an ophthalmology biotech company developing disruptive non-viral vectorized therapies with minimally-invasive delivery technology, today announces the first close of its ...

Reduced vision, also known as vision impairment, is so common that research showed nearly 30 percent of U.S. adults 71 ...

The following is a summary of “Associations between a healthy lifestyle score and retinal neurovascular health,” published in ...

Here's what macular degeneration is, what causes it and how you can expect it to be treated if it affects you or a loved one.

Researchers at Australia's WEHI (Walter and Eliza Hall Institute) medical research center applied AI analysis to over 50,000 ...

Regeneron Pharmaceuticals has announced results from the phase 3 QUASAR trial and its extension study of the phase 3 PULSAR ...